In this study, we investigated the capacity of the Hsp70 tumor-penetrating peptide (TPP), instead of the cmHsp70.1 antibody, to target hybrid AuNPs into mHsp70-positive tumor cells. This evidence concerns the gene HSPA1A and neoplasm.